EP0782388A4 - Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers - Google Patents

Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers

Info

Publication number
EP0782388A4
EP0782388A4 EP95933899A EP95933899A EP0782388A4 EP 0782388 A4 EP0782388 A4 EP 0782388A4 EP 95933899 A EP95933899 A EP 95933899A EP 95933899 A EP95933899 A EP 95933899A EP 0782388 A4 EP0782388 A4 EP 0782388A4
Authority
EP
European Patent Office
Prior art keywords
furocoumarin
sensitizers
viral
photodynamic inactivation
bacterial blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95933899A
Other languages
German (de)
French (fr)
Other versions
EP0782388A1 (en
Inventor
Sang Chul Park
Raymond P Goodrich Jr
Nagender Yerram
Samuel O Sowemino-Coker
Matthew S Platz
Brian Aquila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/311,125 external-priority patent/US5516629A/en
Priority claimed from US08/343,680 external-priority patent/US6251644B1/en
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of EP0782388A1 publication Critical patent/EP0782388A1/en
Publication of EP0782388A4 publication Critical patent/EP0782388A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
EP95933899A 1994-09-22 1995-09-21 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers Withdrawn EP0782388A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US311125 1989-02-15
US08/311,125 US5516629A (en) 1990-04-16 1994-09-22 Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US343680 1994-11-22
US08/343,680 US6251644B1 (en) 1990-04-16 1994-11-22 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US08/427,080 US5789601A (en) 1990-04-16 1995-04-21 Method of inactivation of viral and bacterial blood contaminants
US427080 1995-04-21
US461626 1995-06-05
US08/461,626 US5869701A (en) 1990-04-16 1995-06-05 Method of inactivation of viral and bacterial blood contaminants
PCT/US1995/012069 WO1996008965A1 (en) 1994-09-22 1995-09-21 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers

Publications (2)

Publication Number Publication Date
EP0782388A1 EP0782388A1 (en) 1997-07-09
EP0782388A4 true EP0782388A4 (en) 2000-03-08

Family

ID=27502002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95933899A Withdrawn EP0782388A4 (en) 1994-09-22 1995-09-21 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers

Country Status (5)

Country Link
EP (1) EP0782388A4 (en)
AU (1) AU691672B2 (en)
CA (1) CA2199372A1 (en)
NO (1) NO971350L (en)
WO (1) WO1996008965A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
WO1996039816A1 (en) * 1995-06-07 1996-12-19 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
DE19853425A1 (en) * 1998-11-19 2000-05-25 Martin Roecken Topical composition containing khellin or its derivatives, useful for phototherapy of psoriasis and eczema, has low mitogenic potential
AUPP751298A0 (en) * 1998-12-04 1999-01-07 Csl Limited Inactivation of non-enveloped viruses
DE10031851B4 (en) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamic treatment and UV-B irradiation of a platelet suspension
US8580192B2 (en) 2006-10-31 2013-11-12 Ethicon, Inc. Sterilization of polymeric materials
CN107075478B (en) 2014-07-23 2021-11-09 塞鲁斯公司 Method for preparing platelet product
EP3204426B1 (en) 2014-10-10 2020-11-25 Cerus Corporation Compositions for use in treating viral hemorrhagic fever
WO2016210374A1 (en) 2015-06-26 2016-12-29 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
WO2017070619A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
EA201891577A1 (en) 2016-01-07 2019-02-28 Сирус Корпорейшн SYSTEMS AND METHODS FOR PREPARING PLATELETS
AU2018227586B2 (en) 2017-03-03 2023-12-21 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
WO2019060610A1 (en) 2017-09-20 2019-03-28 Cerus Corporation Compositions and methods for pathogen inactivation of platelets
CA3087253A1 (en) 2017-12-29 2019-07-04 Cerus Corporation Systems and methods for treating biological fluids
US11883544B2 (en) 2019-06-28 2024-01-30 Cerus Corporation System and methods for implementing a biological fluid treatment device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007952A1 (en) * 1989-01-10 1990-07-26 Emil Bisaccia Treatment methods and vaccines
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
WO1996039816A1 (en) * 1995-06-07 1996-12-19 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007952A1 (en) * 1989-01-10 1990-07-26 Emil Bisaccia Treatment methods and vaccines
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
WO1996039816A1 (en) * 1995-06-07 1996-12-19 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BLOOD CELLS (1992), 18(1), 75-89, 1992 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; LYTLE, C. DAVID ET AL: "Antiviral activity of gilvocarcin V plus UVA radiation", XP002126269, retrieved from STN Database accession no. 120:100767 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MATTHEWS, J. L. ET AL: "Inactivation of viruses with photoactive compounds", XP002126272, retrieved from STN Database accession no. 117:22546 CA *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; MIOLO, G. ET AL: "Antiretroviral activity of furocoumarins plus UVA light detected by a replication-defective retrovirus", XP002126268, retrieved from STN Database accession no. 122:50251 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; RONTO, GYORGYI ET AL: "Action spectra for photoinduced inactivation of bacteriophage T7 sensitized by 8-methoxypsoralen and angelicin", XP002126270, retrieved from STN Database accession no. 111:170121 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; TOTH, K. ET AL: "Characterization of new furocoumarin derivatives by their dark and light-mediated action on RNA bacteriophage MS2", XP002126271, retrieved from STN Database accession no. 109:207546 *
J. PHOTOCHEM. PHOTOBIOL., B (1988), 2(2), 209-20 *
J. PHOTOCHEM. PHOTOBIOL., B (1989), 3(4), 497-507 *
J. PHOTOCHEM. PHOTOBIOL., B (1994), 26(3), 241-7 *
PHOTOCHEM. PHOTOBIOL. (1993), 58(6), 818-21 *
See also references of WO9608965A1 *

Also Published As

Publication number Publication date
NO971350L (en) 1997-05-22
AU3638595A (en) 1996-04-09
WO1996008965A1 (en) 1996-03-28
CA2199372A1 (en) 1996-03-28
EP0782388A1 (en) 1997-07-09
AU691672B2 (en) 1998-05-21
NO971350D0 (en) 1997-03-21

Similar Documents

Publication Publication Date Title
ZA912842B (en) Method of inactivation of viral and bacterial blood contaminants
AU7217794A (en) Method of inactivation of viral and bacterial blood contaminants
EP0782388A4 (en) Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
AU4082797A (en) Intracorporeal light treatment of blood
AP9400675A0 (en) Sterilized absorbent core and products made therefrom
ZA944488B (en) System for viral inactivation of blood
EP0724408A4 (en) Multi-functional inner ear treatment and diagnostic system
EP0622063A3 (en) Disposable absorbent articles and methods of making same.
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
ZA9410000B (en) Deep bed filter for killing off micro-organisms and inactivating viruses and use thereof
GB9412711D0 (en) Medical use of bromelain
GB9313188D0 (en) Medical use of enzymes
AU7717396A (en) Inactivation of pathogens using hydroxymethylamines
EP0830057A4 (en) Method of inactivation of viral and bacterial blood contaminants
AU584548B2 (en) Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment
IL130160A0 (en) Inactivation of HIV co-receptors as therapy for HIV infection
AU7954691A (en) Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
AU3816300A (en) Photodynamic inactivation of viruses in biological fluids
AU7103594A (en) Treatment of neonatal hyperbilirubin with metalloporphyrin
AU5627890A (en) Ozone decontamination of blood and blood products
GB2246955B (en) Destruction of microorganisms
AU5136496A (en) Inactivation of pathogens in blood and/or blood products using formaldehyde
AU1565895A (en) Inactivation of viruses present in blood components using chemically-activated compounds
NZ231322A (en) Treatment of viral and/or bacterial infections
NZ233973A (en) Treatment of viral and/or bacterial infections

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970321

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 1/02 A, 7A 01N 43/16 B, 7C 12N 15/00 B, 7A 61K 41/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000119

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20001010

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20031219